WJ
Weinberg Jonathan
Directeur Juridique
OFFICERM
Insider track record
ExecutiveAcross 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Weinberg Jonathan, Directeur Juridique. Director active across 1 company, notably Evolent Health, Inc.. In total, 16 filings have been logged. History available since 4 May 2021. The latest transaction was disclosed on 1 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
43,055 shares0Class A Common StockSEC:0001642833-26-000004:0
2,650 shares@ US$5.740.0024% mcap1.5% of flowClass A Common StockSEC:0001642833-26-000004:1
23,394 shares0Class A Common StockSEC:0001628908-25-000105:0
8,808 shares@ US$8.998.9% of flowClass A Common StockSEC:0001628908-25-000026:0
25,253 shares@ US$13.9537.2% of flowClass A Common StockSEC:0001628908-24-000098:0
21,822 shares0Class A Common StockSEC:0001628908-24-000036:0
11,550 shares0Class A Common StockSEC:0001628908-24-000019:0
12,758 shares0Class A Common StockSEC:0001628908-23-000037:0
11,550 shares0Class A Common StockSEC:0001628908-23-000025:0
14,335 shares@ US$10.2716.8% of flowClass A Common StockSEC:0001628908-22-000113:0
53,789 shares0Class A Common StockSEC:0001628908-22-000041:0
20,000 shares0Class A Common StockSEC:0001628908-22-000031:0
28,000 shares@ US$3.840.021% mcap29.4% of flowClass A Common StockSEC:0001628908-21-000128:0
8,254 shares@ US$3.840.0061% mcap8.6% of flowClass A Common StockSEC:0001628908-21-000120:0
1,900 shares@ US$3.840.0014% mcap2.0% of flowClass A Common StockSEC:0001628908-21-000118:0
20,000 shares@ US$3.840.014% mcap20.2% of flowClass A Common StockSEC:0001628908-21-000056:0
About Weinberg Jonathan
Jonathan Weinberg is the General Counsel at Evolent Health, Inc., a company specializing in healthcare solutions. In his role, Jonathan is responsible for the company's legal affairs, including compliance and risk management. His expertise in business law is essential to support Evolent's operations.